81 results
Page 3 of 5
424B3
EX-4.1
zcu8pd6m9ykx0k
1 Nov 13
Prospectus supplement
12:00am
8-K
EX-4.1
2qweoii
25 Oct 13
Oxygen Biotherapeutics Signs Agreement to Acquire Phase 3, FDA Fast Track Product to Pursue Potential $600 Million Cardiovascular Market
12:00am
424B3
EX-4.1
kjnsyc7y
30 Aug 13
Prospectus supplement
12:00am
424B3
EX-4.2
wwt30f2ozjoxsu
30 Aug 13
Prospectus supplement
12:00am
8-K
EX-4.2
g4xjoj6yqfwwgtzusa
26 Aug 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
0ho2pa
26 Aug 13
Entry into a Material Definitive Agreement
12:00am
424B3
EX-4.1
mg11nrgfu cwrcbf
14 Aug 13
Prospectus supplement
12:00am
424B3
EX-4.2
1l4r2o6
14 Aug 13
Prospectus supplement
12:00am
8-K
EX-4.2
nhsq4a0khwtto5
13 Aug 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
ln8y 0uxs
13 Aug 13
Entry into a Material Definitive Agreement
12:00am
424B3
EX-4.2
atd8eckp6y
25 Jul 13
Prospectus supplement
12:00am
8-K
EX-4.1
2nrwh8 0y
25 Jul 13
Oxygen Biotherapeutics Prices Public Offering
12:00am
8-K
EX-4.2
g7ueuz1xpfc
25 Jul 13
Oxygen Biotherapeutics Prices Public Offering
12:00am
424B3
EX-4.1
55fbdbbg2zjeuk0mr3
25 Jul 13
Prospectus supplement
12:00am
8-K
EX-4.1
behn05mp5cily5cb1
25 Feb 13
Oxygen Biotherapeutics Enters Into Definitive Agreements for Financing
12:00am
8-K
EX-4.3
qrfwxrpxevtcxnrj
25 Feb 13
Oxygen Biotherapeutics Enters Into Definitive Agreements for Financing
12:00am
8-K
EX-4.2
7r3d90y5 yol
25 Feb 13
Oxygen Biotherapeutics Enters Into Definitive Agreements for Financing
12:00am
8-K
EX-4.1
5twj8taowsn78v zj
9 Dec 11
Oxygen Biotherapeutics Announces Registered Financing
12:00am
8-K
EX-4.2
y92ezzn0ebcq wov
9 Dec 11
Oxygen Biotherapeutics Announces Registered Financing
12:00am
8-K
EX-4.1
me4qb8 gld
13 Oct 10
Entry into a Material Definitive Agreement
12:00am